A mixed approach for proving non-inferiority in clinical trials with binary endpoints

被引:21
|
作者
Rousson, Valentin [1 ]
Seifert, Burkhardt [2 ]
机构
[1] Univ Lausanne, Inst Social & Prevent Med, Stat Unit, CH-1005 Lausanne, Switzerland
[2] Univ Zurich, Inst Social & Prevent Med, Biostat Unit, CH-8001 Zurich, Switzerland
关键词
active control; non-inferiofity margin; odds-ratio; difference of proportions; sample size calculation; test for non-inferiority;
D O I
10.1002/bimj.200710410
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
When a new treatment is compared to an established one in a randomized clinical trial, it is standard practice to statistically test for non-inferiority rather than for superiority. When the endpoint is binary, one usually compares two treatments using either an odds-ratio or a difference of proportions. In this paper, we propose a mixed approach which uses both concepts. One first defines the non-inferiority margin using an odds-ratio and one ultimately proves non-inferiority statistically using a difference of proportions. The mixed approach is shown to be more powerful than the conventional odds-ratio approach when the efficacy of the established treatment is known (with good precision) and high (e.g. with more than 56% of success). The gain of power achieved may lead in turn to a substantial reduction in the sample size needed to prove non-inferiority. The mixed approach can be generalized to ordinal endpoints.
引用
收藏
页码:190 / 204
页数:15
相关论文
共 50 条
  • [21] Design of vaccine equivalence/non-inferiority trials with correlated multiple binomial endpoints
    Kong, L.
    Kohberger, R. C.
    Koch, G. G.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2006, 16 (04) : 555 - 572
  • [22] A comparison of testing methods in non-inferiority clinical trials
    Park, Jieun
    Lee, Jae Won
    COMMUNICATIONS FOR STATISTICAL APPLICATIONS AND METHODS, 2024, 31 (06)
  • [23] Bayesian approach to non-inferiority trials for normal means
    Gamalo, M. Amper
    Wu, Rui
    Tiwari, Ram C.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2016, 25 (01) : 221 - 240
  • [24] Bio-creep in non-inferiority clinical trials
    Everson-Stewart, Siobhan
    Emerson, Scott S.
    STATISTICS IN MEDICINE, 2010, 29 (27) : 2769 - 2780
  • [25] Non-inferiority margins employed in clinical trials in Japan
    Gosho, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) : 289 - 298
  • [26] Issues on the selection of non-inferiority margin in clinical trials
    Hou Yan
    Wu Xiao-yan
    Li Kang
    CHINESE MEDICAL JOURNAL, 2009, 122 (04) : 466 - 470
  • [28] Evaluating "superiority", "'equivalence" and "non-inferiority" in clinical trials
    Turan, Fatma Nesrin
    Senocak, Mustafa
    ANNALS OF SAUDI MEDICINE, 2007, 27 (04) : 284 - 288
  • [29] Non-inferiority and equivalence trials
    Ranstam, J.
    Cook, J. A.
    BRITISH JOURNAL OF SURGERY, 2017, 104 (11) : 1578 - 1579
  • [30] The tyranny of non-inferiority trials
    Tannock, Ian F.
    Buyse, Marc
    De Backer, Mickael
    Earl, Helena
    Goldstein, Daniel A.
    Ratain, Mark
    Saltz, Leonard B.
    Sonke, Gabe S.
    Strohbehn, Garth W.
    LANCET ONCOLOGY, 2024, 25 (10): : e520 - e525